

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 7.53962473 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.53962473 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 7.09113878 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.09113878 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.14805934 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.81472542 |
| 7 | negative regulation of execution phase of apoptosis (GO:1900118) | 5.24447815 |
| 8 | alpha-linolenic acid metabolic process (GO:0036109) | 5.19898342 |
| 9 | high-density lipoprotein particle remodeling (GO:0034375) | 5.11172087 |
| 10 | bile acid biosynthetic process (GO:0006699) | 5.03798648 |
| 11 | tryptophan catabolic process (GO:0006569) | 4.93661393 |
| 12 | indole-containing compound catabolic process (GO:0042436) | 4.93661393 |
| 13 | indolalkylamine catabolic process (GO:0046218) | 4.93661393 |
| 14 | kynurenine metabolic process (GO:0070189) | 4.90341377 |
| 15 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 4.90143782 |
| 16 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.88206473 |
| 17 | protein carboxylation (GO:0018214) | 4.88206473 |
| 18 | tryptophan metabolic process (GO:0006568) | 4.87438306 |
| 19 | negative regulation of fibrinolysis (GO:0051918) | 4.85946510 |
| 20 | urea metabolic process (GO:0019627) | 4.85560482 |
| 21 | urea cycle (GO:0000050) | 4.85560482 |
| 22 | complement activation, alternative pathway (GO:0006957) | 4.78386078 |
| 23 | glyoxylate metabolic process (GO:0046487) | 4.75583036 |
| 24 | reverse cholesterol transport (GO:0043691) | 4.74416661 |
| 25 | tyrosine metabolic process (GO:0006570) | 4.72642565 |
| 26 | regulation of protein activation cascade (GO:2000257) | 4.69822710 |
| 27 | regulation of fibrinolysis (GO:0051917) | 4.67117065 |
| 28 | sulfur amino acid catabolic process (GO:0000098) | 4.61666577 |
| 29 | regulation of cholesterol esterification (GO:0010872) | 4.59015549 |
| 30 | glycerophospholipid catabolic process (GO:0046475) | 4.50453850 |
| 31 | aromatic amino acid family metabolic process (GO:0009072) | 4.48435049 |
| 32 | bile acid metabolic process (GO:0008206) | 4.48364785 |
| 33 | nitrogen cycle metabolic process (GO:0071941) | 4.46484618 |
| 34 | phospholipid efflux (GO:0033700) | 4.40153593 |
| 35 | regulation of complement activation (GO:0030449) | 4.40100764 |
| 36 | cysteine metabolic process (GO:0006534) | 4.39244401 |
| 37 | protein-lipid complex remodeling (GO:0034368) | 4.39184723 |
| 38 | macromolecular complex remodeling (GO:0034367) | 4.39184723 |
| 39 | plasma lipoprotein particle remodeling (GO:0034369) | 4.39184723 |
| 40 | epithelial cell fate commitment (GO:0072148) | 4.27484181 |
| 41 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.22911749 |
| 42 | serine family amino acid catabolic process (GO:0009071) | 4.22165872 |
| 43 | insulin secretion (GO:0030073) | 4.17509404 |
| 44 | regulation of triglyceride catabolic process (GO:0010896) | 4.17298539 |
| 45 | acylglycerol homeostasis (GO:0055090) | 4.10032507 |
| 46 | triglyceride homeostasis (GO:0070328) | 4.10032507 |
| 47 | peptide hormone processing (GO:0016486) | 4.07975877 |
| 48 | positive regulation of gluconeogenesis (GO:0045722) | 4.05927502 |
| 49 | cellular ketone body metabolic process (GO:0046950) | 4.02159513 |
| 50 | bile acid and bile salt transport (GO:0015721) | 4.01780284 |
| 51 | cholesterol efflux (GO:0033344) | 4.01513577 |
| 52 | alpha-amino acid catabolic process (GO:1901606) | 4.00398573 |
| 53 | negative regulation of sterol transport (GO:0032372) | 3.96863742 |
| 54 | negative regulation of cholesterol transport (GO:0032375) | 3.96863742 |
| 55 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 3.96690196 |
| 56 | endocrine pancreas development (GO:0031018) | 3.95331021 |
| 57 | plasma lipoprotein particle clearance (GO:0034381) | 3.88817781 |
| 58 | inositol phosphate catabolic process (GO:0071545) | 3.86315510 |
| 59 | lysine metabolic process (GO:0006553) | 3.85672500 |
| 60 | lysine catabolic process (GO:0006554) | 3.85672500 |
| 61 | auditory receptor cell differentiation (GO:0042491) | 3.84638494 |
| 62 | plasma lipoprotein particle assembly (GO:0034377) | 3.82560655 |
| 63 | positive regulation of histone H3-K4 methylation (GO:0051571) | 3.82300401 |
| 64 | positive regulation of insulin secretion (GO:0032024) | 3.80108392 |
| 65 | glutamate metabolic process (GO:0006536) | 3.79041487 |
| 66 | homocysteine metabolic process (GO:0050667) | 3.78945605 |
| 67 | amino-acid betaine metabolic process (GO:0006577) | 3.78678949 |
| 68 | cellular amino acid catabolic process (GO:0009063) | 3.74064136 |
| 69 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.73125817 |
| 70 | cellular modified amino acid catabolic process (GO:0042219) | 3.72620516 |
| 71 | indolalkylamine metabolic process (GO:0006586) | 3.69040647 |
| 72 | inositol phosphate dephosphorylation (GO:0046855) | 3.66877693 |
| 73 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 3.66877693 |
| 74 | low-density lipoprotein particle remodeling (GO:0034374) | 3.65274033 |
| 75 | respiratory chain complex IV assembly (GO:0008535) | 3.65207063 |
| 76 | coenzyme catabolic process (GO:0009109) | 3.64062639 |
| 77 | complement activation, classical pathway (GO:0006958) | 3.59414517 |
| 78 | negative regulation of lipase activity (GO:0060192) | 3.50999127 |
| 79 | regulation of cholesterol homeostasis (GO:2000188) | 3.50936793 |
| 80 | L-alpha-amino acid transmembrane transport (GO:1902475) | 3.49493029 |
| 81 | protein-lipid complex assembly (GO:0065005) | 3.49474413 |
| 82 | ketone body metabolic process (GO:1902224) | 3.48015723 |
| 83 | cytochrome complex assembly (GO:0017004) | 3.47984102 |
| 84 | phospholipid homeostasis (GO:0055091) | 3.47751714 |
| 85 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.46244202 |
| 86 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.44907304 |
| 87 | imidazole-containing compound metabolic process (GO:0052803) | 3.44749871 |
| 88 | regulation of extracellular matrix disassembly (GO:0010715) | 3.43313896 |
| 89 | plasma lipoprotein particle organization (GO:0071827) | 3.42780087 |
| 90 | nitric oxide biosynthetic process (GO:0006809) | 3.41979071 |
| 91 | complement activation (GO:0006956) | 3.38855234 |
| 92 | negative regulation of digestive system process (GO:0060457) | 3.38409396 |
| 93 | cellular biogenic amine catabolic process (GO:0042402) | 3.37084263 |
| 94 | amine catabolic process (GO:0009310) | 3.37084263 |
| 95 | regulation of bile acid biosynthetic process (GO:0070857) | 3.36044101 |
| 96 | benzene-containing compound metabolic process (GO:0042537) | 3.35396462 |
| 97 | polyol catabolic process (GO:0046174) | 3.34811681 |
| 98 | cytolysis (GO:0019835) | 3.33889920 |
| 99 | fibrinolysis (GO:0042730) | 3.33557383 |
| 100 | regulation of glucokinase activity (GO:0033131) | 3.32782745 |
| 101 | regulation of hexokinase activity (GO:1903299) | 3.32782745 |
| 102 | macroautophagy (GO:0016236) | 3.32408931 |
| 103 | positive regulation of lipid catabolic process (GO:0050996) | 3.32157785 |
| 104 | negative regulation of protein activation cascade (GO:2000258) | 3.31249080 |
| 105 | cellular glucuronidation (GO:0052695) | 3.31095693 |
| 106 | intestinal cholesterol absorption (GO:0030299) | 3.30850196 |
| 107 | carboxylic acid catabolic process (GO:0046395) | 3.30083866 |
| 108 | organic acid catabolic process (GO:0016054) | 3.30083866 |
| 109 | phenylpropanoid metabolic process (GO:0009698) | 3.28500907 |
| 110 | short-chain fatty acid metabolic process (GO:0046459) | 3.28382674 |
| 111 | cholesterol homeostasis (GO:0042632) | 3.28048269 |
| 112 | detection of calcium ion (GO:0005513) | 3.27878807 |
| 113 | positive regulation of peptide hormone secretion (GO:0090277) | 3.27266376 |
| 114 | drug catabolic process (GO:0042737) | 3.26797254 |
| 115 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.26424955 |
| 116 | protein-lipid complex subunit organization (GO:0071825) | 3.26135209 |
| 117 | glandular epithelial cell differentiation (GO:0002067) | 3.25567938 |
| 118 | positive regulation of calcium ion import (GO:0090280) | 3.25217043 |
| 119 | protein activation cascade (GO:0072376) | 3.24981741 |
| 120 | regulation of execution phase of apoptosis (GO:1900117) | 3.24221552 |
| 121 | lipoprotein metabolic process (GO:0042157) | 3.23671464 |
| 122 | sterol homeostasis (GO:0055092) | 3.22395773 |
| 123 | aldehyde catabolic process (GO:0046185) | 3.22189988 |
| 124 | glycine metabolic process (GO:0006544) | 3.21603189 |
| 125 | arginine metabolic process (GO:0006525) | 3.20066034 |
| 126 | monocarboxylic acid catabolic process (GO:0072329) | 3.14708004 |
| 127 | positive regulation of peptide secretion (GO:0002793) | 3.14144092 |
| 128 | blood coagulation, intrinsic pathway (GO:0007597) | 3.13521445 |
| 129 | cofactor catabolic process (GO:0051187) | 3.13445460 |
| 130 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.12537378 |
| 131 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.12537378 |
| 132 | serine family amino acid metabolic process (GO:0009069) | 3.10780208 |
| 133 | signal peptide processing (GO:0006465) | 2.98708656 |
| 134 | lactate metabolic process (GO:0006089) | 2.96576604 |
| 135 | regulation of neurotransmitter uptake (GO:0051580) | 2.90384110 |
| 136 | epithelial cilium movement (GO:0003351) | 2.86917395 |
| 137 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.85297667 |
| 138 | negative regulation of complement activation (GO:0045916) | 2.85076628 |
| 139 | axoneme assembly (GO:0035082) | 2.81961591 |
| 140 | nephron epithelium morphogenesis (GO:0072088) | 2.80504593 |
| 141 | nephron tubule morphogenesis (GO:0072078) | 2.80504593 |
| 142 | peptide hormone secretion (GO:0030072) | 2.79497383 |
| 143 | xenobiotic catabolic process (GO:0042178) | 2.78514152 |
| 144 | nodal signaling pathway (GO:0038092) | 2.77525844 |
| 145 | S-adenosylmethionine metabolic process (GO:0046500) | 2.76959179 |
| 146 | nitric oxide mediated signal transduction (GO:0007263) | 2.73964440 |
| 147 | regulation of insulin secretion (GO:0050796) | 2.73765177 |
| 148 | positive regulation of meiosis (GO:0045836) | 2.73594390 |
| 149 | peptide secretion (GO:0002790) | 2.72898492 |
| 150 | zinc ion homeostasis (GO:0055069) | 2.72660320 |
| 151 | alanine transport (GO:0032328) | 2.71672025 |
| 152 | zinc ion transmembrane transport (GO:0071577) | 2.71510549 |
| 153 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic proc | 2.68367259 |
| 154 | regulation of autophagic vacuole assembly (GO:2000785) | 2.67906984 |
| 155 | protein complex biogenesis (GO:0070271) | 2.67712056 |
| 156 | positive regulation of macroautophagy (GO:0016239) | 2.65287848 |
| 157 | phospholipid catabolic process (GO:0009395) | 2.64393304 |
| 158 | regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178) | 2.63111897 |
| 159 | proline transport (GO:0015824) | 2.63018757 |
| 160 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.61516244 |
| 161 | sphingomyelin metabolic process (GO:0006684) | 2.57413138 |
| 162 | potassium ion export (GO:0071435) | 2.56868726 |
| 163 | renal tubule morphogenesis (GO:0061333) | 2.55260953 |
| 164 | regulation of peptide hormone secretion (GO:0090276) | 2.54298815 |
| 165 | positive regulation of glycolytic process (GO:0045821) | 2.54189865 |
| 166 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.53990096 |
| 167 | positive regulation of meiotic cell cycle (GO:0051446) | 2.52569125 |
| 168 | zinc ion transport (GO:0006829) | 2.51024770 |
| 169 | dendritic spine morphogenesis (GO:0060997) | 2.49791175 |
| 170 | regulation of acrosome reaction (GO:0060046) | 2.48216180 |
| 171 | regulation of peptide secretion (GO:0002791) | 2.47811704 |
| 172 | positive regulation of response to extracellular stimulus (GO:0032106) | 2.44690777 |
| 173 | positive regulation of response to nutrient levels (GO:0032109) | 2.44690777 |
| 174 | somite rostral/caudal axis specification (GO:0032525) | 2.44473196 |
| 175 | negative regulation of hormone biosynthetic process (GO:0032353) | 2.44263730 |
| 176 | C-terminal protein lipidation (GO:0006501) | 2.43877138 |
| 177 | astrocyte differentiation (GO:0048708) | 2.43654886 |
| 178 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.42386628 |
| 179 | dentate gyrus development (GO:0021542) | 2.40813475 |
| 180 | heme transport (GO:0015886) | 2.40673553 |
| 181 | regulation of vacuole organization (GO:0044088) | 2.40407462 |
| 182 | peptide transport (GO:0015833) | 2.39964878 |
| 183 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.39851684 |
| 184 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.39851684 |
| 185 | cilium movement (GO:0003341) | 2.38581820 |
| 186 | positive regulation of hormone secretion (GO:0046887) | 2.38567751 |
| 187 | cellular zinc ion homeostasis (GO:0006882) | 2.37967425 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.25312743 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.23885490 |
| 3 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.84765976 |
| 4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.45838297 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.80889895 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.28884279 |
| 7 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.96323345 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.66208533 |
| 9 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.38917681 |
| 10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.34428190 |
| 11 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.85403014 |
| 12 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.40411541 |
| 13 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.33986335 |
| 14 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.31029387 |
| 15 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.06646605 |
| 16 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.06020251 |
| 17 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.0975692 |
| 18 | GATA1_22025678_ChIP-Seq_K562_Human | 1.96173020 |
| 19 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.95792396 |
| 20 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.85006483 |
| 21 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.80334519 |
| 22 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.79141398 |
| 23 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.71333024 |
| 24 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.68783033 |
| 25 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.65739706 |
| 26 | P300_19829295_ChIP-Seq_ESCs_Human | 1.64778518 |
| 27 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.62112796 |
| 28 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.60496106 |
| 29 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.58645896 |
| 30 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.57784528 |
| 31 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.55504955 |
| 32 | * FUS_26573619_Chip-Seq_HEK293_Human | 1.52595187 |
| 33 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.50960074 |
| 34 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.48846069 |
| 35 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.48244952 |
| 36 | STAT3_23295773_ChIP-Seq_U87_Human | 1.45550541 |
| 37 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.45428030 |
| 38 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.44548271 |
| 39 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.44396987 |
| 40 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.44240153 |
| 41 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.43810551 |
| 42 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.43172170 |
| 43 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.42936019 |
| 44 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.41983038 |
| 45 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.40943420 |
| 46 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.40043143 |
| 47 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.38706931 |
| 48 | AR_25329375_ChIP-Seq_VCAP_Human | 1.38384481 |
| 49 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.35433467 |
| 50 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.34255952 |
| 51 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.33243196 |
| 52 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.33190137 |
| 53 | TCF4_23295773_ChIP-Seq_U87_Human | 1.32634072 |
| 54 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.31634934 |
| 55 | VDR_22108803_ChIP-Seq_LS180_Human | 1.31119934 |
| 56 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.30806341 |
| 57 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.30787462 |
| 58 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.30014226 |
| 59 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.29950198 |
| 60 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.29622064 |
| 61 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.29622064 |
| 62 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.29583664 |
| 63 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.26818418 |
| 64 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.25499793 |
| 65 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.23645837 |
| 66 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.23562506 |
| 67 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.22913399 |
| 68 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.22899295 |
| 69 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.22490268 |
| 70 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.22466567 |
| 71 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.21582841 |
| 72 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.18470692 |
| 73 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.17498509 |
| 74 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.17498509 |
| 75 | * HTT_18923047_ChIP-ChIP_STHdh_Human | 1.13414531 |
| 76 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.12140487 |
| 77 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.11947148 |
| 78 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.11224674 |
| 79 | EWS_26573619_Chip-Seq_HEK293_Human | 1.10519446 |
| 80 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.10326703 |
| 81 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.10232172 |
| 82 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.10232172 |
| 83 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.08423711 |
| 84 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.08090601 |
| 85 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.06609113 |
| 86 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.06528851 |
| 87 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.06179179 |
| 88 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.05294904 |
| 89 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.04753380 |
| 90 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.03438673 |
| 91 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.02764410 |
| 92 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.01503733 |
| 93 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.01351574 |
| 94 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.01278582 |
| 95 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.00092988 |
| 96 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.99333010 |
| 97 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.99184976 |
| 98 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.99127971 |
| 99 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.98964282 |
| 100 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.98767921 |
| 101 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.98640267 |
| 102 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.98465676 |
| 103 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.98139871 |
| 104 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.97926812 |
| 105 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.96542624 |
| 106 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.93369038 |
| 107 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.92423799 |
| 108 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.88206376 |
| 109 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.87241598 |
| 110 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.86285388 |
| 111 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.85817117 |
| 112 | GATA1_19941826_ChIP-Seq_K562_Human | 0.80954607 |
| 113 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 0.80422013 |
| 114 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.80361363 |
| 115 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.79726735 |
| 116 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.78025162 |
| 117 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.78020528 |
| 118 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.77576420 |
| 119 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.76444050 |
| 120 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.76321255 |
| 121 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.74159597 |
| 122 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.71919510 |
| 123 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.70336603 |
| 124 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.69507473 |
| 125 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.67807504 |
| 126 | * SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.66606735 |
| 127 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.66080383 |
| 128 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.65405391 |
| 129 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.65307947 |
| 130 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.64744428 |
| 131 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.64744428 |
| 132 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.63004533 |
| 133 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.62949811 |
| 134 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.62900469 |
| 135 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.62846316 |
| 136 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.61968817 |
| 137 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.61744902 |
| 138 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.60822801 |
| 139 | AR_20517297_ChIP-Seq_VCAP_Human | 0.60788921 |
| 140 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.59036458 |
| 141 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.58915615 |
| 142 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.58686320 |
| 143 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.57767665 |
| 144 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.56705343 |
| 145 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.55027449 |
| 146 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.53487427 |
| 147 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.53424830 |
| 148 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.53270820 |
| 149 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.52693805 |
| 150 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.52439738 |
| 151 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.52047630 |
| 152 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.51926991 |
| 153 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.51837351 |
| 154 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.51767406 |
| 155 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.51546929 |
| 156 | CBP_21632823_ChIP-Seq_H3396_Human | 0.50923227 |
| 157 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.50141828 |
| 158 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.49454308 |
| 159 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.49361410 |
| 160 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.49012209 |
| 161 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.48768570 |
| 162 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.48711921 |
| 163 | GATA2_19941826_ChIP-Seq_K562_Human | 0.47055225 |
| 164 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.46631075 |
| 165 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.46221364 |
| 166 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.45973316 |
| 167 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.44981546 |
| 168 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.43427713 |
| 169 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.43146594 |
| 170 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.42507303 |
| 171 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.41807719 |
| 172 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.41325147 |
| 173 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.41233731 |
| 174 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.40510667 |
| 175 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.40510667 |
| 176 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.40020770 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.23359056 |
| 2 | MP0005360_urolithiasis | 6.11120754 |
| 3 | MP0005365_abnormal_bile_salt | 5.77555658 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 5.57261862 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.21614449 |
| 6 | MP0003252_abnormal_bile_duct | 3.90273303 |
| 7 | MP0003195_calcinosis | 3.85015102 |
| 8 | MP0003806_abnormal_nucleotide_metabolis | 3.34610581 |
| 9 | MP0009840_abnormal_foam_cell | 3.27732796 |
| 10 | MP0010329_abnormal_lipoprotein_level | 3.24193705 |
| 11 | MP0002163_abnormal_gland_morphology | 3.08208437 |
| 12 | MP0005332_abnormal_amino_acid | 2.71003247 |
| 13 | MP0010234_abnormal_vibrissa_follicle | 2.50999611 |
| 14 | MP0005083_abnormal_biliary_tract | 2.47669225 |
| 15 | MP0003787_abnormal_imprinting | 2.45735263 |
| 16 | MP0000013_abnormal_adipose_tissue | 2.41867036 |
| 17 | MP0003191_abnormal_cellular_cholesterol | 2.37125407 |
| 18 | * MP0004019_abnormal_vitamin_homeostasis | 2.33058564 |
| 19 | MP0001666_abnormal_nutrient_absorption | 2.25777120 |
| 20 | MP0002138_abnormal_hepatobiliary_system | 2.11710552 |
| 21 | MP0003011_delayed_dark_adaptation | 2.09845435 |
| 22 | MP0006072_abnormal_retinal_apoptosis | 2.06991841 |
| 23 | MP0003122_maternal_imprinting | 2.06372981 |
| 24 | MP0002118_abnormal_lipid_homeostasis | 2.01640542 |
| 25 | MP0009046_muscle_twitch | 1.90632388 |
| 26 | MP0000609_abnormal_liver_physiology | 1.90567957 |
| 27 | MP0008877_abnormal_DNA_methylation | 1.87047141 |
| 28 | MP0003183_abnormal_peptide_metabolism | 1.77363677 |
| 29 | MP0003868_abnormal_feces_composition | 1.76716670 |
| 30 | MP0001764_abnormal_homeostasis | 1.73396177 |
| 31 | MP0005551_abnormal_eye_electrophysiolog | 1.58991842 |
| 32 | MP0005379_endocrine/exocrine_gland_phen | 1.58701429 |
| 33 | MP0001984_abnormal_olfaction | 1.50844700 |
| 34 | MP0003283_abnormal_digestive_organ | 1.48366668 |
| 35 | MP0005319_abnormal_enzyme/_coenzyme | 1.48281426 |
| 36 | MP0002837_dystrophic_cardiac_calcinosis | 1.46733212 |
| 37 | MP0005220_abnormal_exocrine_pancreas | 1.46452426 |
| 38 | MP0009643_abnormal_urine_homeostasis | 1.43468504 |
| 39 | MP0001944_abnormal_pancreas_morphology | 1.42226093 |
| 40 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.41931491 |
| 41 | MP0002078_abnormal_glucose_homeostasis | 1.41852949 |
| 42 | MP0001501_abnormal_sleep_pattern | 1.38897373 |
| 43 | MP0005253_abnormal_eye_physiology | 1.37940683 |
| 44 | MP0005084_abnormal_gallbladder_morpholo | 1.36718711 |
| 45 | MP0002909_abnormal_adrenal_gland | 1.34512989 |
| 46 | MP0002638_abnormal_pupillary_reflex | 1.33250123 |
| 47 | MP0008004_abnormal_stomach_pH | 1.32383423 |
| 48 | MP0001756_abnormal_urination | 1.26516186 |
| 49 | MP0004133_heterotaxia | 1.26344188 |
| 50 | MP0009745_abnormal_behavioral_response | 1.24593060 |
| 51 | MP0000003_abnormal_adipose_tissue | 1.22659118 |
| 52 | MP0009697_abnormal_copulation | 1.20853946 |
| 53 | MP0002938_white_spotting | 1.20529463 |
| 54 | MP0005058_abnormal_lysosome_morphology | 1.19081241 |
| 55 | MP0002928_abnormal_bile_duct | 1.17985181 |
| 56 | MP0000372_irregular_coat_pigmentation | 1.17158517 |
| 57 | MP0000631_abnormal_neuroendocrine_gland | 1.16934912 |
| 58 | MP0005636_abnormal_mineral_homeostasis | 1.16760670 |
| 59 | MP0005174_abnormal_tail_pigmentation | 1.15679758 |
| 60 | MP0004043_abnormal_pH_regulation | 1.09883602 |
| 61 | MP0002693_abnormal_pancreas_physiology | 1.07411030 |
| 62 | MP0005535_abnormal_body_temperature | 1.07165882 |
| 63 | MP0004885_abnormal_endolymph | 1.05520759 |
| 64 | MP0000604_amyloidosis | 1.04624066 |
| 65 | MP0002064_seizures | 1.03901742 |
| 66 | MP0005645_abnormal_hypothalamus_physiol | 1.03810883 |
| 67 | MP0003879_abnormal_hair_cell | 1.03726175 |
| 68 | MP0002971_abnormal_brown_adipose | 1.03073027 |
| 69 | MP0005408_hypopigmentation | 1.00893734 |
| 70 | MP0005248_abnormal_Harderian_gland | 1.00816226 |
| 71 | MP0002734_abnormal_mechanical_nocicepti | 1.00445936 |
| 72 | MP0005670_abnormal_white_adipose | 0.98963192 |
| 73 | MP0002272_abnormal_nervous_system | 0.98579232 |
| 74 | MP0003186_abnormal_redox_activity | 0.97462825 |
| 75 | MP0003172_abnormal_lysosome_physiology | 0.97406346 |
| 76 | MP0006054_spinal_hemorrhage | 0.97196811 |
| 77 | MP0000639_abnormal_adrenal_gland | 0.97004047 |
| 78 | MP0001905_abnormal_dopamine_level | 0.96742257 |
| 79 | MP0000598_abnormal_liver_morphology | 0.96187976 |
| 80 | MP0000569_abnormal_digit_pigmentation | 0.94452025 |
| 81 | MP0000427_abnormal_hair_cycle | 0.94114370 |
| 82 | MP0005375_adipose_tissue_phenotype | 0.92344595 |
| 83 | MP0003121_genomic_imprinting | 0.92323829 |
| 84 | MP0003656_abnormal_erythrocyte_physiolo | 0.91788791 |
| 85 | MP0002557_abnormal_social/conspecific_i | 0.91672489 |
| 86 | * MP0009642_abnormal_blood_homeostasis | 0.90907068 |
| 87 | MP0001970_abnormal_pain_threshold | 0.90583965 |
| 88 | MP0003690_abnormal_glial_cell | 0.89842805 |
| 89 | MP0000516_abnormal_urinary_system | 0.89464876 |
| 90 | MP0005367_renal/urinary_system_phenotyp | 0.89464876 |
| 91 | MP0001765_abnormal_ion_homeostasis | 0.89361882 |
| 92 | MP0008961_abnormal_basal_metabolism | 0.86397741 |
| 93 | MP0010678_abnormal_skin_adnexa | 0.86080161 |
| 94 | MP0009780_abnormal_chondrocyte_physiolo | 0.85301263 |
| 95 | MP0001986_abnormal_taste_sensitivity | 0.83759758 |
| 96 | MP0004142_abnormal_muscle_tone | 0.83656981 |
| 97 | * MP0003953_abnormal_hormone_level | 0.83597700 |
| 98 | MP0005334_abnormal_fat_pad | 0.82434282 |
| 99 | MP0000538_abnormal_urinary_bladder | 0.82181560 |
| 100 | MP0005666_abnormal_adipose_tissue | 0.81803432 |
| 101 | MP0000015_abnormal_ear_pigmentation | 0.81571908 |
| 102 | MP0005448_abnormal_energy_balance | 0.79979608 |
| 103 | MP0004215_abnormal_myocardial_fiber | 0.79237371 |
| 104 | MP0002229_neurodegeneration | 0.79089900 |
| 105 | MP0002733_abnormal_thermal_nociception | 0.78760006 |
| 106 | MP0003329_amyloid_beta_deposits | 0.77929213 |
| 107 | MP0002295_abnormal_pulmonary_circulatio | 0.77913519 |
| 108 | MP0004924_abnormal_behavior | 0.77904031 |
| 109 | MP0005386_behavior/neurological_phenoty | 0.77904031 |
| 110 | MP0004130_abnormal_muscle_cell | 0.77047325 |
| 111 | MP0009763_increased_sensitivity_to | 0.76458144 |
| 112 | MP0001968_abnormal_touch/_nociception | 0.76270298 |
| 113 | MP0010368_abnormal_lymphatic_system | 0.75527966 |
| 114 | MP0003123_paternal_imprinting | 0.75434418 |
| 115 | MP0001661_extended_life_span | 0.74744589 |
| 116 | * MP0008469_abnormal_protein_level | 0.74149587 |
| 117 | MP0003633_abnormal_nervous_system | 0.73011204 |
| 118 | MP0004085_abnormal_heartbeat | 0.72831644 |
| 119 | MP0002168_other_aberrant_phenotype | 0.72515496 |
| 120 | MP0005647_abnormal_sex_gland | 0.69713867 |
| 121 | MP0005451_abnormal_body_composition | 0.69474986 |
| 122 | MP0006036_abnormal_mitochondrial_physio | 0.67340924 |
| 123 | MP0003959_abnormal_lean_body | 0.65248985 |
| 124 | MP0003300_gastrointestinal_ulcer | 0.64930026 |
| 125 | MP0002090_abnormal_vision | 0.64438855 |
| 126 | MP0002876_abnormal_thyroid_physiology | 0.62009824 |
| 127 | MP0005376_homeostasis/metabolism_phenot | 0.61779866 |
| 128 | MP0000230_abnormal_systemic_arterial | 0.60017621 |
| 129 | MP0003638_abnormal_response/metabolism_ | 0.56845528 |
| 130 | MP0002254_reproductive_system_inflammat | 0.54579778 |
| 131 | MP0004264_abnormal_extraembryonic_tissu | 0.54235586 |
| 132 | MP0009764_decreased_sensitivity_to | 0.52588917 |
| 133 | MP0003075_altered_response_to | 0.52244178 |
| 134 | MP0010386_abnormal_urinary_bladder | 0.50166747 |
| 135 | MP0001502_abnormal_circadian_rhythm | 0.50059335 |
| 136 | MP0009765_abnormal_xenobiotic_induced | 0.49498423 |
| 137 | MP0002136_abnormal_kidney_physiology | 0.48239947 |
| 138 | MP0006082_CNS_inflammation | 0.46735159 |
| 139 | MP0002069_abnormal_eating/drinking_beha | 0.43591972 |
| 140 | MP0005395_other_phenotype | 0.43352351 |
| 141 | MP0009672_abnormal_birth_weight | 0.42961158 |
| 142 | MP0002970_abnormal_white_adipose | 0.42643294 |
| 143 | MP0005266_abnormal_metabolism | 0.42485528 |
| 144 | MP0003631_nervous_system_phenotype | 0.42315565 |
| 145 | MP0005646_abnormal_pituitary_gland | 0.41691079 |
| 146 | MP0004270_analgesia | 0.41122908 |
| 147 | MP0005075_abnormal_melanosome_morpholog | 0.40699649 |
| 148 | MP0003705_abnormal_hypodermis_morpholog | 0.38703182 |
| 149 | MP0002877_abnormal_melanocyte_morpholog | 0.38649105 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.27081502 |
| 2 | Deep venous thrombosis (HP:0002625) | 6.09373574 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 5.94957378 |
| 4 | Prolonged partial thromboplastin time (HP:0003645) | 5.50448833 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.44837714 |
| 6 | Complement deficiency (HP:0004431) | 5.36260048 |
| 7 | Hypoglycemic coma (HP:0001325) | 5.33916370 |
| 8 | Xanthomatosis (HP:0000991) | 5.31388801 |
| 9 | Hypobetalipoproteinemia (HP:0003563) | 5.07521393 |
| 10 | Hyperlipoproteinemia (HP:0010980) | 4.77941973 |
| 11 | Ketosis (HP:0001946) | 4.55721596 |
| 12 | Hypoglycemic seizures (HP:0002173) | 4.43679809 |
| 13 | Ketoacidosis (HP:0001993) | 4.40377996 |
| 14 | Hyperinsulinemic hypoglycemia (HP:0000825) | 4.29417637 |
| 15 | Hypolipoproteinemia (HP:0010981) | 4.27024321 |
| 16 | Hypoalphalipoproteinemia (HP:0003233) | 4.14932792 |
| 17 | Abnormality of the common coagulation pathway (HP:0010990) | 4.05173243 |
| 18 | Intestinal atresia (HP:0011100) | 3.94407060 |
| 19 | Joint hemorrhage (HP:0005261) | 3.87476015 |
| 20 | Double outlet right ventricle (HP:0001719) | 3.86886053 |
| 21 | Congenital malformation of the right heart (HP:0011723) | 3.86886053 |
| 22 | Abnormality of complement system (HP:0005339) | 3.80585395 |
| 23 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.79964606 |
| 24 | Epidermoid cyst (HP:0200040) | 3.76113930 |
| 25 | Abnormality of the intrinsic pathway (HP:0010989) | 3.71458842 |
| 26 | Hyperammonemia (HP:0001987) | 3.64666576 |
| 27 | Hyperglycemia (HP:0003074) | 3.64559169 |
| 28 | Hyperglycinemia (HP:0002154) | 3.56981981 |
| 29 | Retinal atrophy (HP:0001105) | 3.55316398 |
| 30 | Conjugated hyperbilirubinemia (HP:0002908) | 3.48021034 |
| 31 | Systemic lupus erythematosus (HP:0002725) | 3.45512035 |
| 32 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.41652168 |
| 33 | Hypothermia (HP:0002045) | 3.39518365 |
| 34 | Late onset (HP:0003584) | 3.37263359 |
| 35 | Symptomatic seizures (HP:0011145) | 3.37061266 |
| 36 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.28064058 |
| 37 | Abnormality of methionine metabolism (HP:0010901) | 3.25859132 |
| 38 | Hyperglycinuria (HP:0003108) | 3.24425958 |
| 39 | Fat malabsorption (HP:0002630) | 3.22740015 |
| 40 | Vascular calcification (HP:0004934) | 3.16476236 |
| 41 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.09826608 |
| 42 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.09588439 |
| 43 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.05124391 |
| 44 | Hyperbilirubinemia (HP:0002904) | 3.04441055 |
| 45 | Abnormality of glycine metabolism (HP:0010895) | 3.00926796 |
| 46 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.00926796 |
| 47 | Abnormality of endocrine pancreas physiology (HP:0012093) | 3.00728695 |
| 48 | Abnormality of the pancreatic islet cells (HP:0006476) | 3.00728695 |
| 49 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.96436911 |
| 50 | Glomerulonephritis (HP:0000099) | 2.95944596 |
| 51 | Large for gestational age (HP:0001520) | 2.92542240 |
| 52 | Hypercholesterolemia (HP:0003124) | 2.87683683 |
| 53 | Abnormality of the renal cortex (HP:0011035) | 2.81670033 |
| 54 | Enlarged penis (HP:0000040) | 2.80065552 |
| 55 | Medial flaring of the eyebrow (HP:0010747) | 2.76449914 |
| 56 | Cardiovascular calcification (HP:0011915) | 2.76383691 |
| 57 | Progressive macrocephaly (HP:0004481) | 2.73642737 |
| 58 | Skin nodule (HP:0200036) | 2.71249583 |
| 59 | Gout (HP:0001997) | 2.65506075 |
| 60 | Congenital sensorineural hearing impairment (HP:0008527) | 2.61616698 |
| 61 | Pancreatic fibrosis (HP:0100732) | 2.57673846 |
| 62 | Nephronophthisis (HP:0000090) | 2.57209416 |
| 63 | Renal cortical cysts (HP:0000803) | 2.56873308 |
| 64 | Delayed CNS myelination (HP:0002188) | 2.55479244 |
| 65 | Postural tremor (HP:0002174) | 2.54751192 |
| 66 | Irritability (HP:0000737) | 2.49814647 |
| 67 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.49782641 |
| 68 | Mitral stenosis (HP:0001718) | 2.49373631 |
| 69 | Abnormal gallbladder morphology (HP:0012437) | 2.48425701 |
| 70 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.46944740 |
| 71 | Abnormality of nucleobase metabolism (HP:0010932) | 2.46080288 |
| 72 | Progressive neurologic deterioration (HP:0002344) | 2.44376868 |
| 73 | Abnormality of purine metabolism (HP:0004352) | 2.44229111 |
| 74 | Pancreatic cysts (HP:0001737) | 2.43129805 |
| 75 | Abnormal albumin level (HP:0012116) | 2.42842495 |
| 76 | Hypoalbuminemia (HP:0003073) | 2.42842495 |
| 77 | Acute necrotizing encephalopathy (HP:0006965) | 2.42659320 |
| 78 | Tubular atrophy (HP:0000092) | 2.38977739 |
| 79 | Methylmalonic acidemia (HP:0002912) | 2.37637715 |
| 80 | Generalized aminoaciduria (HP:0002909) | 2.36741068 |
| 81 | Hepatocellular carcinoma (HP:0001402) | 2.35385730 |
| 82 | Metabolic acidosis (HP:0001942) | 2.34938948 |
| 83 | Attenuation of retinal blood vessels (HP:0007843) | 2.34274078 |
| 84 | Enlarged kidneys (HP:0000105) | 2.31801107 |
| 85 | Gaze-evoked nystagmus (HP:0000640) | 2.27124963 |
| 86 | Congenital stationary night blindness (HP:0007642) | 2.26114510 |
| 87 | Myocardial infarction (HP:0001658) | 2.23248248 |
| 88 | Sensorimotor neuropathy (HP:0007141) | 2.22270703 |
| 89 | Furrowed tongue (HP:0000221) | 2.21821855 |
| 90 | Tongue fasciculations (HP:0001308) | 2.20853415 |
| 91 | Dysostosis multiplex (HP:0000943) | 2.19194452 |
| 92 | Mitochondrial inheritance (HP:0001427) | 2.18274899 |
| 93 | Vacuolated lymphocytes (HP:0001922) | 2.16492736 |
| 94 | 3-Methylglutaconic aciduria (HP:0003535) | 2.15447204 |
| 95 | Conjunctival hamartoma (HP:0100780) | 2.14848819 |
| 96 | Amyloidosis (HP:0011034) | 2.14446430 |
| 97 | True hermaphroditism (HP:0010459) | 2.14402750 |
| 98 | Abnormality of the renal medulla (HP:0100957) | 2.14304688 |
| 99 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.12704032 |
| 100 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.11423088 |
| 101 | Dicarboxylic aciduria (HP:0003215) | 2.11423088 |
| 102 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.10988968 |
| 103 | Abnormality of serum amino acid levels (HP:0003112) | 2.09165045 |
| 104 | Acute encephalopathy (HP:0006846) | 2.09007392 |
| 105 | Lethargy (HP:0001254) | 2.08403824 |
| 106 | Hematochezia (HP:0002573) | 2.08042324 |
| 107 | Aqueductal stenosis (HP:0002410) | 2.07870540 |
| 108 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.07472701 |
| 109 | Hypoplasia of the fovea (HP:0007750) | 2.07472701 |
| 110 | Hypomagnesemia (HP:0002917) | 2.06973558 |
| 111 | Molar tooth sign on MRI (HP:0002419) | 2.06277089 |
| 112 | Abnormality of midbrain morphology (HP:0002418) | 2.06277089 |
| 113 | Cholelithiasis (HP:0001081) | 2.05591122 |
| 114 | Steatorrhea (HP:0002570) | 2.04589595 |
| 115 | Testicular neoplasm (HP:0010788) | 2.04235479 |
| 116 | Abnormal drinking behavior (HP:0030082) | 2.02795116 |
| 117 | Polydipsia (HP:0001959) | 2.02795116 |
| 118 | Increased CSF lactate (HP:0002490) | 2.02537811 |
| 119 | Hypochromic microcytic anemia (HP:0004840) | 2.02203930 |
| 120 | Spontaneous abortion (HP:0005268) | 2.01611523 |
| 121 | EEG with generalized epileptiform discharges (HP:0011198) | 2.00180095 |
| 122 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.99905220 |
| 123 | Hepatic necrosis (HP:0002605) | 1.98364417 |
| 124 | Poor suck (HP:0002033) | 1.98333954 |
| 125 | Hyperthyroidism (HP:0000836) | 1.98062395 |
| 126 | Methylmalonic aciduria (HP:0012120) | 1.97658630 |
| 127 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.95702072 |
| 128 | Brushfield spots (HP:0001088) | 1.94694153 |
| 129 | Muscular hypotonia of the trunk (HP:0008936) | 1.94120249 |
| 130 | Hypokinesia (HP:0002375) | 1.94101192 |
| 131 | Abnormality of abdominal situs (HP:0011620) | 1.94057951 |
| 132 | Abdominal situs inversus (HP:0003363) | 1.94057951 |
| 133 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.93571856 |
| 134 | Mucopolysacchariduria (HP:0008155) | 1.93571856 |
| 135 | Urethral obstruction (HP:0000796) | 1.93275824 |
| 136 | Abnormality of the gallbladder (HP:0005264) | 1.92685376 |
| 137 | Epileptiform EEG discharges (HP:0011182) | 1.92297721 |
| 138 | Congenital primary aphakia (HP:0007707) | 1.91586363 |
| 139 | Neuroendocrine neoplasm (HP:0100634) | 1.89962039 |
| 140 | Renal Fanconi syndrome (HP:0001994) | 1.89433604 |
| 141 | Gait imbalance (HP:0002141) | 1.89315614 |
| 142 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.88676708 |
| 143 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.88232433 |
| 144 | Pancreatitis (HP:0001733) | 1.88163570 |
| 145 | Abnormal sex determination (HP:0012244) | 1.87682384 |
| 146 | Sex reversal (HP:0012245) | 1.87682384 |
| 147 | Anxiety (HP:0000739) | 1.87173957 |
| 148 | Lipid accumulation in hepatocytes (HP:0006561) | 1.86407162 |
| 149 | Progressive cerebellar ataxia (HP:0002073) | 1.86382342 |
| 150 | Proximal tubulopathy (HP:0000114) | 1.86179460 |
| 151 | Hypsarrhythmia (HP:0002521) | 1.85910585 |
| 152 | Insulin resistance (HP:0000855) | 1.85612500 |
| 153 | Abnormality of renal resorption (HP:0011038) | 1.85476660 |
| 154 | Acanthocytosis (HP:0001927) | 1.84916783 |
| 155 | Hamartoma of the eye (HP:0010568) | 1.84686682 |
| 156 | Pheochromocytoma (HP:0002666) | 1.84472600 |
| 157 | Gastrointestinal atresia (HP:0002589) | 1.84291341 |
| 158 | Agitation (HP:0000713) | 1.83904360 |
| 159 | Status epilepticus (HP:0002133) | 1.83903834 |
| 160 | Menorrhagia (HP:0000132) | 1.83742745 |
| 161 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.79035785 |
| 162 | Esophageal varix (HP:0002040) | 1.78541317 |
| 163 | Nephritis (HP:0000123) | 1.78520644 |
| 164 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.77927631 |
| 165 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.77927631 |
| 166 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.77927631 |
| 167 | Cerebral edema (HP:0002181) | 1.75736398 |
| 168 | Abnormality of urine glucose concentration (HP:0011016) | 1.75435584 |
| 169 | Glycosuria (HP:0003076) | 1.75435584 |
| 170 | Cholecystitis (HP:0001082) | 1.75339677 |
| 171 | Abnormal gallbladder physiology (HP:0012438) | 1.75339677 |
| 172 | Neonatal onset (HP:0003623) | 1.74129754 |
| 173 | Rickets (HP:0002748) | 1.72357729 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAPK15 | 7.70404657 |
| 2 | WNK3 | 5.34211703 |
| 3 | PIK3CG | 4.65581117 |
| 4 | INSRR | 3.64704216 |
| 5 | MST4 | 3.39106798 |
| 6 | BCKDK | 3.28202824 |
| 7 | PHKG1 | 3.15438323 |
| 8 | PHKG2 | 3.15438323 |
| 9 | ERN1 | 2.98719284 |
| 10 | WNK4 | 2.94940528 |
| 11 | MAP4K2 | 2.92611327 |
| 12 | TAOK3 | 2.64521465 |
| 13 | SIK1 | 2.35776550 |
| 14 | FRK | 2.28055847 |
| 15 | MAP2K6 | 2.25017125 |
| 16 | FGFR4 | 2.19480321 |
| 17 | CASK | 2.04639759 |
| 18 | ADRBK2 | 2.00012032 |
| 19 | PTK6 | 1.96066419 |
| 20 | FGFR3 | 1.83793830 |
| 21 | MAP3K2 | 1.61478157 |
| 22 | TGFBR2 | 1.59004851 |
| 23 | MAP3K12 | 1.57060125 |
| 24 | TRPM7 | 1.49688185 |
| 25 | ACVR1B | 1.43765334 |
| 26 | STK3 | 1.43566766 |
| 27 | BMPR1B | 1.42142791 |
| 28 | PRKCE | 1.41437192 |
| 29 | NLK | 1.37711287 |
| 30 | STK24 | 1.33059388 |
| 31 | ERBB4 | 1.31259903 |
| 32 | STK38L | 1.30512858 |
| 33 | PRKD3 | 1.30291382 |
| 34 | UHMK1 | 1.28910530 |
| 35 | TRIB3 | 1.25771499 |
| 36 | MAP2K4 | 1.23884506 |
| 37 | CSNK1G1 | 1.17826619 |
| 38 | PNCK | 1.16675453 |
| 39 | FLT3 | 1.14326364 |
| 40 | DAPK2 | 1.10809577 |
| 41 | JAK2 | 1.10164949 |
| 42 | TNIK | 1.09729592 |
| 43 | PKN2 | 1.09269161 |
| 44 | TNK2 | 1.06888478 |
| 45 | RIPK1 | 1.05991720 |
| 46 | DYRK1B | 1.05763400 |
| 47 | PTK2B | 1.02287464 |
| 48 | STK39 | 1.02281460 |
| 49 | PLK2 | 1.01915296 |
| 50 | WNK1 | 1.00949856 |
| 51 | KSR2 | 0.99791097 |
| 52 | NEK9 | 0.99603397 |
| 53 | CAMK2D | 0.95751522 |
| 54 | MAPK11 | 0.91674016 |
| 55 | GRK7 | 0.91547503 |
| 56 | ERBB3 | 0.91058251 |
| 57 | CSNK1G3 | 0.90500166 |
| 58 | CSNK1G2 | 0.90106553 |
| 59 | MKNK2 | 0.88646520 |
| 60 | OXSR1 | 0.87966648 |
| 61 | PRKCI | 0.87461526 |
| 62 | CAMKK1 | 0.87337550 |
| 63 | PAK3 | 0.84527554 |
| 64 | MAP3K1 | 0.83207659 |
| 65 | CAMKK2 | 0.83103290 |
| 66 | JAK1 | 0.79728669 |
| 67 | CSK | 0.79679714 |
| 68 | HIPK2 | 0.79334973 |
| 69 | TYK2 | 0.78876531 |
| 70 | RET | 0.77688995 |
| 71 | IRAK3 | 0.75893725 |
| 72 | PINK1 | 0.75567422 |
| 73 | PRKAA2 | 0.72255642 |
| 74 | PTK2 | 0.71483789 |
| 75 | MST1R | 0.71451174 |
| 76 | EPHA3 | 0.69463129 |
| 77 | PRKCH | 0.68542668 |
| 78 | CAMK1D | 0.68422272 |
| 79 | TAOK1 | 0.67790653 |
| 80 | STK11 | 0.65559275 |
| 81 | PDPK1 | 0.64896817 |
| 82 | PRKAA1 | 0.63903226 |
| 83 | STK4 | 0.60213841 |
| 84 | GSK3A | 0.59913572 |
| 85 | NTRK1 | 0.59416406 |
| 86 | PRKCZ | 0.59380331 |
| 87 | YES1 | 0.59308470 |
| 88 | ZAK | 0.58922716 |
| 89 | SGK3 | 0.58524524 |
| 90 | PDK1 | 0.54464620 |
| 91 | PRKG1 | 0.53746580 |
| 92 | SGK2 | 0.53092023 |
| 93 | SGK223 | 0.53046269 |
| 94 | SGK494 | 0.53046269 |
| 95 | CSNK1A1L | 0.53002824 |
| 96 | CSF1R | 0.52411146 |
| 97 | LMTK2 | 0.52214142 |
| 98 | PRKACG | 0.51916554 |
| 99 | MAPK13 | 0.51001353 |
| 100 | MAP3K3 | 0.49439795 |
| 101 | EIF2AK3 | 0.48705085 |
| 102 | PRKCG | 0.48440631 |
| 103 | EPHB1 | 0.46547102 |
| 104 | MAP3K7 | 0.46468559 |
| 105 | AKT3 | 0.46035924 |
| 106 | MAP2K7 | 0.45063796 |
| 107 | CAMK2A | 0.43486991 |
| 108 | CAMK1G | 0.43223063 |
| 109 | ERBB2 | 0.43213285 |
| 110 | MAPK7 | 0.43090788 |
| 111 | CAMK4 | 0.41739520 |
| 112 | PRKACB | 0.41653497 |
| 113 | CSNK1D | 0.41543728 |
| 114 | ITK | 0.41147981 |
| 115 | TLK1 | 0.40780277 |
| 116 | IGF1R | 0.40264394 |
| 117 | MUSK | 0.40253406 |
| 118 | EIF2AK1 | 0.39866745 |
| 119 | NUAK1 | 0.38519898 |
| 120 | MAP3K9 | 0.37254507 |
| 121 | MAP2K2 | 0.36853203 |
| 122 | CAMK2G | 0.36757635 |
| 123 | ADRBK1 | 0.36722702 |
| 124 | FGFR2 | 0.36508552 |
| 125 | IRAK1 | 0.36484540 |
| 126 | MTOR | 0.35741540 |
| 127 | GRK1 | 0.35375366 |
| 128 | NTRK3 | 0.35086680 |
| 129 | STK38 | 0.34706471 |
| 130 | RPS6KB1 | 0.33445197 |
| 131 | MAP2K1 | 0.33358150 |
| 132 | LIMK1 | 0.32070809 |
| 133 | MAPKAPK3 | 0.31728937 |
| 134 | MYLK | 0.31607488 |
| 135 | TBK1 | 0.31012859 |
| 136 | BMPR2 | 0.30436056 |
| 137 | PRKCQ | 0.30118440 |
| 138 | CDC42BPA | 0.29685696 |
| 139 | MAPK4 | 0.29303756 |
| 140 | EPHA4 | 0.29283595 |
| 141 | AKT2 | 0.28696555 |
| 142 | MET | 0.28580650 |
| 143 | STK16 | 0.28169568 |
| 144 | PAK6 | 0.28076359 |
| 145 | MAP3K13 | 0.28053746 |
| 146 | FGFR1 | 0.27918273 |
| 147 | PRKCA | 0.27883952 |
| 148 | ROCK1 | 0.27273515 |
| 149 | CSNK1E | 0.26760432 |
| 150 | FER | 0.25961809 |
| 151 | CHUK | 0.25920997 |
| 152 | MAPK12 | 0.25520424 |
| 153 | RPS6KA3 | 0.24676112 |
| 154 | ABL2 | 0.24351116 |
| 155 | MAP3K4 | 0.23905800 |
| 156 | PDGFRA | 0.21880786 |
| 157 | PRKG2 | 0.21199392 |
| 158 | PRKD1 | 0.20661788 |
| 159 | PRKD2 | 0.20470108 |
| 160 | PRKACA | 0.20045591 |
| 161 | CSNK1A1 | 0.19572119 |
| 162 | SGK1 | 0.18649809 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.16728970 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 4.12323107 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.01701995 |
| 4 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.97260120 |
| 5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.96574468 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.93730357 |
| 7 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.67781617 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.66766704 |
| 9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.54702639 |
| 10 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.38306159 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.36607052 |
| 12 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.32438276 |
| 13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.31183918 |
| 14 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.19274651 |
| 15 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.13593750 |
| 16 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.12853380 |
| 17 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.12024996 |
| 18 | Peroxisome_Homo sapiens_hsa04146 | 1.94038367 |
| 19 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.87153859 |
| 20 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.79175715 |
| 21 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.78005093 |
| 22 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.77661964 |
| 23 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.74761977 |
| 24 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.72188768 |
| 25 | Bile secretion_Homo sapiens_hsa04976 | 1.70599813 |
| 26 | Histidine metabolism_Homo sapiens_hsa00340 | 1.69321916 |
| 27 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.64011521 |
| 28 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.61123554 |
| 29 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.58619068 |
| 30 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.58519526 |
| 31 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.56720888 |
| 32 | Retinol metabolism_Homo sapiens_hsa00830 | 1.54297887 |
| 33 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.51666577 |
| 34 | ABC transporters_Homo sapiens_hsa02010 | 1.50961244 |
| 35 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.47364878 |
| 36 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.46674503 |
| 37 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.45555454 |
| 38 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.43276235 |
| 39 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.38766924 |
| 40 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.36141608 |
| 41 | Phototransduction_Homo sapiens_hsa04744 | 1.35871257 |
| 42 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.31562359 |
| 43 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.30711836 |
| 44 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.29968392 |
| 45 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.28528003 |
| 46 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.27215680 |
| 47 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.25790598 |
| 48 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.24052846 |
| 49 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.22137539 |
| 50 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.22065077 |
| 51 | Parkinsons disease_Homo sapiens_hsa05012 | 1.15785253 |
| 52 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.12056565 |
| 53 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.07791696 |
| 54 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.03291539 |
| 55 | Mineral absorption_Homo sapiens_hsa04978 | 1.01560099 |
| 56 | Alzheimers disease_Homo sapiens_hsa05010 | 0.99151461 |
| 57 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.94835827 |
| 58 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.94576511 |
| 59 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.93770568 |
| 60 | Prion diseases_Homo sapiens_hsa05020 | 0.93647915 |
| 61 | Renin secretion_Homo sapiens_hsa04924 | 0.93000774 |
| 62 | Circadian entrainment_Homo sapiens_hsa04713 | 0.87733423 |
| 63 | Carbon metabolism_Homo sapiens_hsa01200 | 0.84786552 |
| 64 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.83272749 |
| 65 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.83029682 |
| 66 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.82317613 |
| 67 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.82172653 |
| 68 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.81835308 |
| 69 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.80757078 |
| 70 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.79031345 |
| 71 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.77889093 |
| 72 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.76741913 |
| 73 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.76334298 |
| 74 | Lysine degradation_Homo sapiens_hsa00310 | 0.76064440 |
| 75 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.75762923 |
| 76 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.74842542 |
| 77 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.74618348 |
| 78 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.73146563 |
| 79 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.72863208 |
| 80 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.69474176 |
| 81 | Insulin secretion_Homo sapiens_hsa04911 | 0.67467040 |
| 82 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.66504343 |
| 83 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.63591901 |
| 84 | Huntingtons disease_Homo sapiens_hsa05016 | 0.63075073 |
| 85 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.60051746 |
| 86 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.58434397 |
| 87 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.53907401 |
| 88 | Salivary secretion_Homo sapiens_hsa04970 | 0.53300330 |
| 89 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.51958726 |
| 90 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.51825695 |
| 91 | Long-term depression_Homo sapiens_hsa04730 | 0.50865127 |
| 92 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.50471145 |
| 93 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.49897572 |
| 94 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.46128176 |
| 95 | Sulfur relay system_Homo sapiens_hsa04122 | 0.45686337 |
| 96 | Protein export_Homo sapiens_hsa03060 | 0.43933900 |
| 97 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.43730258 |
| 98 | Morphine addiction_Homo sapiens_hsa05032 | 0.43012235 |
| 99 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.42392006 |
| 100 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.41092585 |
| 101 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.40683098 |
| 102 | Metabolic pathways_Homo sapiens_hsa01100 | 0.39963235 |
| 103 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.39867890 |
| 104 | Lysosome_Homo sapiens_hsa04142 | 0.39343701 |
| 105 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.38218732 |
| 106 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.38039224 |
| 107 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.37358470 |
| 108 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.36987681 |
| 109 | Nicotine addiction_Homo sapiens_hsa05033 | 0.35915944 |
| 110 | Insulin resistance_Homo sapiens_hsa04931 | 0.34424998 |
| 111 | Other glycan degradation_Homo sapiens_hsa00511 | 0.34273983 |
| 112 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.32173901 |
| 113 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.31629550 |
| 114 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.30681598 |
| 115 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.28526911 |
| 116 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.28109282 |
| 117 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.26295263 |
| 118 | Galactose metabolism_Homo sapiens_hsa00052 | 0.23932182 |
| 119 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.22371411 |
| 120 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.22100197 |
| 121 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.21226546 |
| 122 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.20503667 |
| 123 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.20096202 |
| 124 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.19862581 |
| 125 | Circadian rhythm_Homo sapiens_hsa04710 | 0.14548065 |
| 126 | GABAergic synapse_Homo sapiens_hsa04727 | 0.13387225 |
| 127 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.13254547 |
| 128 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.13229383 |
| 129 | Cocaine addiction_Homo sapiens_hsa05030 | 0.10941139 |
| 130 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.08878487 |
| 131 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.07612699 |
| 132 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.07433166 |
| 133 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.04351006 |
| 134 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.01084291 |
| 135 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.01069910 |

